» Articles » PMID: 32747698

Common Genetic Risk Variants Identified in the SPARK Cohort Support DDHD2 As a Candidate Risk Gene for Autism

Overview
Date 2020 Aug 5
PMID 32747698
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Autism spectrum disorder (ASD) is a highly heritable neurodevelopmental disorder. Large genetically informative cohorts of individuals with ASD have led to the identification of a limited number of common genome-wide significant (GWS) risk loci to date. However, many more common genetic variants are expected to contribute to ASD risk given the high heritability. Here, we performed a genome-wide association study (GWAS) on 6222 case-pseudocontrol pairs from the Simons Foundation Powering Autism Research for Knowledge (SPARK) dataset to identify additional common genetic risk factors and molecular mechanisms underlying risk for ASD. We identified one novel GWS locus from the SPARK GWAS and four significant loci, including an additional novel locus from meta-analysis with a previous GWAS. We replicated the previous observation of significant enrichment of ASD heritability within regulatory regions of the developing cortex, indicating that disruption of gene regulation during neurodevelopment is critical for ASD risk. We further employed a massively parallel reporter assay (MPRA) and identified a putative causal variant at the novel locus from SPARK GWAS with strong impacts on gene regulation (rs7001340). Expression quantitative trait loci data demonstrated an association between the risk allele and decreased expression of DDHD2 (DDHD domain containing 2) in both adult and prenatal brains. In conclusion, by integrating genetic association data with multi-omic gene regulatory annotations and experimental validation, we fine-mapped a causal risk variant and demonstrated that DDHD2 is a novel gene associated with ASD risk.

Citing Articles

Comparing Alzheimer's genes in African, European, and Amerindian induced pluripotent stem cell-derived microglia.

Moura S, Nasciben L, Ramirez A, Coombs L, Rivero J, Van Booven D Alzheimers Dement. 2025; 21(2):e70031.

PMID: 40008916 PMC: 11863361. DOI: 10.1002/alz.70031.


A neuro-immune axis of transcriptomic dysregulation within the subgenual anterior cingulate cortex in schizophrenia.

Smith R, Mihalik A, Akula N, Auluck P, Marenco S, Raznahan A bioRxiv. 2025; .

PMID: 39990369 PMC: 11844519. DOI: 10.1101/2025.02.14.638357.


Translation of genome-wide association study: from genomic signals to biological insights.

Bruner W, Grant S Front Genet. 2024; 15:1375481.

PMID: 39421299 PMC: 11484060. DOI: 10.3389/fgene.2024.1375481.


Progress towards understanding risk factor mechanisms in the development of autism spectrum disorders.

Bryers A, Hawkes C, Parkin E, Dawson N Biochem Soc Trans. 2024; 52(5):2047-2058.

PMID: 39221783 PMC: 11555714. DOI: 10.1042/BST20231004.


An axis of genetic heterogeneity in autism is indexed by age at diagnosis and is associated with varying developmental and mental health profiles.

Zhang X, Grove J, Gu Y, Buus C, Nielsen L, Neufeld S medRxiv. 2024; .

PMID: 39132493 PMC: 11312648. DOI: 10.1101/2024.07.31.24311279.


References
1.
Gaugler T, Klei L, Sanders S, Bodea C, Goldberg A, Lee A . Most genetic risk for autism resides with common variation. Nat Genet. 2014; 46(8):881-5. PMC: 4137411. DOI: 10.1038/ng.3039. View

2.
Barbeira A, Dickinson S, Bonazzola R, Zheng J, Wheeler H, Torres J . Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics. Nat Commun. 2018; 9(1):1825. PMC: 5940825. DOI: 10.1038/s41467-018-03621-1. View

3.
Dong S, Walker M, Carriero N, DiCola M, Willsey A, Ye A . De novo insertions and deletions of predominantly paternal origin are associated with autism spectrum disorder. Cell Rep. 2014; 9(1):16-23. PMC: 4194132. DOI: 10.1016/j.celrep.2014.08.068. View

4.
ORoak B, Vives L, Girirajan S, Karakoc E, Krumm N, Coe B . Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature. 2012; 485(7397):246-50. PMC: 3350576. DOI: 10.1038/nature10989. View

5.
Inloes J, Hsu K, Dix M, Viader A, Masuda K, Takei T . The hereditary spastic paraplegia-related enzyme DDHD2 is a principal brain triglyceride lipase. Proc Natl Acad Sci U S A. 2014; 111(41):14924-9. PMC: 4205627. DOI: 10.1073/pnas.1413706111. View